how much is a glp-1 glp 1 medication Market Overview: Agonists and the Obesity Market Medicare Spending on Ozempic and

Description

, Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial, Journal of the American Medical Association 325, no

GLP-1 medications (short for Glucagon-Like Peptide-1) are a class of prescription drugs originally developed to help people with type 2 diabetes manage blood sugar

These patients often experience multiple comorbidities, such as diabetes and cardiovascular disease, where GLP-1 therapies offer additional health benefits beyond weight loss

Dyspepsia, characterized by upper abdominal discomfort, early satiety, or postprandial fullness, may affect a similar proportion of patients and can contribute to reduced caloric intake and weight loss, though it may also impact quality of life if severe or persistent